Bamlanivimab

A4DAB032 | Approved
SARS-CoV-2 Spike
G1 / None
Abcellera Eli Lilly and Company National Institute of Allergy and Infectious Diseases
Approved
Whole mAb
LY 3819253 LY3819253 LY-3819253 LY CoV 555 LY-CoV-555
—
IMGT PubChem (434321760) PubChem (434370493) PubChem (442064635) PubChem (472422427) PubChem (481155474) PubChem (483929052) PubChem (505057019) Thera-SAbDab YAbS
Avg A4D Score
-0.6193
Score Range
-0.67 to -0.54
Structures
3
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB032_7kmg_D_E 7kmg 100% -0.6478 6.5 9.0 -0.0307 -0.7318
A4DAB032_7kmg_A_B 7kmg 100% -0.6675 6.5 9.0 -0.0081 -0.7566
A4DAB032_7l3n_D_E 7l3n 100% -0.5425 6.5 9.0 0.017 -0.7059